Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

915 questions in 93 reviews · Emergency and Critical Care

current versions
No studies 141 · 15.4%Ungraded 22 · 2.4%Very low 216 · 23.6%Low 272 · 29.7%Moderate 188 · 20.5%High 76 · 8.3%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Polyclonal intravenous immunoglobulin (IVIG) vs placebo or no intervention
Low risk of bias adult studies, mortality all‐cause ‐ IgM‐enriched IVIG · adult patients with sepsis, severe sepsis and septic shock
Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock (2013) · Cochrane
RR 0.82 [0.56, 1.19]2 studies · 262 participantsModerate
Monoclonal antibodies vs placebo
Anti‐endotoxins versus placebo, all‐cause mortality · patients with sepsis, severe sepsis, septic shock
Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock (2013) · Cochrane
RR 0.92 [0.79, 1.06]8 studies · 4676 participantsLow
Intervention NR
ICU length of stay (general intensive care patients) · Adult patients in intensive care
Pulmonary artery catheters for adult patients in intensive care (2013) · Cochrane
no estimate extracted4 studies · 2723 participantsHigh
Intervention NR
Hospital length of stay (general intensive care patients) · Adult patients in intensive care
Pulmonary artery catheters for adult patients in intensive care (2013) · Cochrane
no estimate extracted2 studies · 1689 participantsHigh
Intervention NR
Hospital length of stay (high‐risk surgical patients) · Adult patients in intensive care
Pulmonary artery catheters for adult patients in intensive care (2013) · Cochrane
no estimate extracted5 studies · 503 participantsHigh
Intervention NR
Cost of care (hospital charges, 1000s of US dollars) · Adult patients in intensive care
Pulmonary artery catheters for adult patients in intensive care (2013) · Cochrane
no estimate extracted2 studies · 191 participantsLow
Intervention NR
Combined mortality of all studies · Adult patients in intensive care
Pulmonary artery catheters for adult patients in intensive care (2013) · Cochrane
RR 1.0113 studies · 5686 participantsHigh
Primary analysis: less vs more frequent
Catheter‐related BSI as defined using criteria specified by Maki 2006; Mermel 2009; and O'Grady 2002 · patients with intravenous administration set replacement
Optimal timing for intravascular administration set replacement (2013) · Cochrane
RR 1.06 [0.66, 1.68]8 studies · 1794 participantsLow
Primary analysis: less vs more frequent
Infusate‐related BSI as defined using criteria specified by O'Grady 2002 · patients with intravenous administration set replacement
Optimal timing for intravascular administration set replacement (2013) · Cochrane
RR 0.69 [0.31, 1.51]11 studies · 1847 participantsLow
Primary analysis: less vs more frequent
Infusate colonization any positive quantitative culture of infusate · patients with intravenous administration set replacement
Optimal timing for intravascular administration set replacement (2013) · Cochrane
RR 1.15 [0.7, 1.86]8 studies · 1549 participantsLow
Primary analysis: less vs more frequent
Catheter colonization any positive semiquantitative or quantitative culture from the distal catheter segment · patients with intravenous administration set replacement
Optimal timing for intravascular administration set replacement (2013) · Cochrane
RR 1.08 [0.94, 1.24]4 studies · 1448 participantsModerate
Primary analysis: less vs more frequent
All‐cause BSI any positive blood culture drawn from a peripheral vein taken whilst the IVD is in situ, or within 48 hours of removal (O'Grady 2002) · patients with intravenous administration set replacement
Optimal timing for intravascular administration set replacement (2013) · Cochrane
RR 0.82 [0.48, 1.4]6 studies · 2297 participantsLow
Primary analysis: less vs more frequent
Mortality · patients with intravenous administration set replacement
Optimal timing for intravascular administration set replacement (2013) · Cochrane
RR 1.85 [1.01, 3.38]2 studies · 1355 participantsLow
Intervention NR
d mortality · mechanically ventilated participants with acute lung injury and acute respiratory distress syndrome
Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute… (2013) · Cochrane
no estimate extracted2 studies · 302 participantsLow
Intervention NR
Number of days free of mechanical ventilation in a 28 d period · mechanically ventilated participants with acute lung injury and acute respiratory distress syndrome
Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute… (2013) · Cochrane
no estimate extracted2 studies · 302 participantsLow
Intervention NR
Adverse events · mechanically ventilated participants with acute lung injury and acute respiratory distress syndrome
Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute… (2013) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Hypoxia · mechanically ventilated participants with acute lung injury and acute respiratory distress syndrome
Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute… (2013) · Cochrane
no estimate extracted2 studies · 302 participantsLow
Intervention NR
Pneumothorax · mechanically ventilated participants with acute lung injury and acute respiratory distress syndrome
Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute… (2013) · Cochrane
no estimate extracted2 studies · 302 participantsLow
Intervention NR
Hypotension · mechanically ventilated participants with acute lung injury and acute respiratory distress syndrome
Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute… (2013) · Cochrane
no estimate extracted2 studies · 302 participantsLow
Intervention NR
Bradycardia · mechanically ventilated participants with acute lung injury and acute respiratory distress syndrome
Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute… (2013) · Cochrane
no estimate extracted2 studies · 302 participantsLow
Intervention NR
Cardiac arrest · mechanically ventilated participants with acute lung injury and acute respiratory distress syndrome
Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute… (2013) · Cochrane
no estimate extracted2 studies · 302 participantsLow
Noninvasive vs invasive weaning
Mortality—COPD · intubated adults with respiratory failure
Noninvasive positive‐pressure ventilation as a weaning strategy for intubated adults with respiratory failure (2013) · Cochrane
RR 0.36 [0.24, 0.56]9 studies · 632 participantsModerate
Noninvasive vs invasive weaning
Mortality—mixed · intubated adults with respiratory failure
Noninvasive positive‐pressure ventilation as a weaning strategy for intubated adults with respiratory failure (2013) · Cochrane
RR 0.81 [0.47, 1.4]7 studies · 362 participantsLow
Noninvasive vs invasive weaning
Weaning failure · patients with intubated adults with respiratory failure
Noninvasive positive‐pressure ventilation as a weaning strategy for intubated adults with respiratory failure (2013) · Cochrane
RR 0.63 [0.42, 0.96]8 studies · 605 participantsModerate
Noninvasive vs invasive weaning
Nosocomial pneumonia · patients with intubated adults with respiratory failure
Noninvasive positive‐pressure ventilation as a weaning strategy for intubated adults with respiratory failure (2013) · Cochrane
RR 0.25 [0.15, 0.43]14 studies · 953 participantsLow
Noninvasive vs invasive weaning
Average duration of ventilation related to weaning · patients with intubated adults with respiratory failure
Noninvasive positive‐pressure ventilation as a weaning strategy for intubated adults with respiratory failure (2013) · Cochrane
no estimate extracted9 studies · 645 participantsLow
Noninvasive vs invasive weaning
Reintubation · patients with intubated adults with respiratory failure
Noninvasive positive‐pressure ventilation as a weaning strategy for intubated adults with respiratory failure (2013) · Cochrane
RR 0.65 [0.44, 0.97]10 studies · 789 participantsModerate
Intervention NR
Reduction in airway resistance Measured as a reduction in additional effective resistance (ΔRrs) and interrupter resistance (Rint) Assessed before treatment and 30 minutes after the end of each modality of administration · mechanically ventilated adults with need for aerosol bronchodilator therapy
Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving… (2013) · Cochrane
no estimate extracted2 studies · 28 participantsModerate
Intervention NR
Mortality during critical care unit admission Measured using mortality rate in intervention and comparison groups During critical care admission · mechanically ventilated adults with need for aerosol bronchodilator therapy
Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving… (2013) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Duration of mechanical ventilation Measured as number of days · mechanically ventilated adults with need for aerosol bronchodilator therapy
Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving… (2013) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Adverse changes to haemodynamic observations Measured as a change in heart rate (beats per minute) Assessed before treatment and 30 minutes after the end of each modality of administration · mechanically ventilated adults with need for aerosol bronchodilator therapy
Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving… (2013) · Cochrane
no estimate extracted2 studies · 28 participantsModerate
Fibrinogen concentrate vs any comparator
Mortality · bleeding patients or at risk of severe bleeding
Fibrinogen concentrate in bleeding patients (2013) · Cochrane
RR 0.28 [0.03, 2.33]2 studies · 81 participantsVery low
Fibrinogen concentrate vs any comparator
Incidence of allogenic blood transfusion Proportion of participants transfused with RBC, FFP, PLT and/or cryo · bleeding patients or at risk of severe bleeding
Fibrinogen concentrate in bleeding patients (2013) · Cochrane
RR 0.47 [0.31, 0.72]5 studies · 207 participantsVery low
Fibrinogen concentrate vs any comparator
Thrombotic episodes (arterial and venous graft occlusion, pulmonary embolus, deep venous thrombosis) Proportion with event · bleeding patients or at risk of severe bleeding
Fibrinogen concentrate in bleeding patients (2013) · Cochrane
RR 1.03 [0.27, 3.97]3 studies · 124 participantsVery low
Fibrinogen concentrate vs any comparator
Intensive care unit (ICU) stay Duration of stay (hours) · bleeding patients or at risk of severe bleeding
Fibrinogen concentrate in bleeding patients (2013) · Cochrane
no estimate extracted3 studies · 112 participantsVery low
Fibrinogen concentrate vs any comparator
Re‐operation due to persistent bleeding Events during admission · bleeding patients or at risk of severe bleeding
Fibrinogen concentrate in bleeding patients (2013) · Cochrane
RR 0.68 [0.01, 36.71]2 studies · 124 participantsVery low
Internal jugular vs subclavian insertion: long‐term catheterization
Catheter‐related infectious complications ‐ Exit site infection · cancer patients
Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane
RR 7 [0.88, 55.86]1 study · 200 participantsLow
Femoral vs subclavian insertion: short‐term catheterization
Immediate mechanical complications ‐ Total mechanical complications · critically ill patients
Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane
RR 0.92 [0.56, 1.51]1 study · 289 participantsHigh
Femoral vs subclavian insertion: short‐term catheterization
Immediate mechanical complications ‐ Major mechanical complications · critically ill patients
Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane
RR 0.5 [0.09, 2.67]1 study · 289 participantsHigh
Femoral vs internal jugular insertion: short‐term catheterization
Catheter‐related infectious complications ‐ Catheter colonization · critically ill patients who were expected to require support with renal replacement therapy
Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane
RR 1.04 [0.8, 1.36]1 study · 637 participantsModerate
Femoral vs internal jugular insertion: short‐term catheterization
Catheter‐related infectious complications ‐ Catheter related bloodstream infection · critically ill patients who were expected to require support with renal replacement therapy
Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane
RR 0.58 [0.14, 2.4]1 study · 637 participantsModerate
Femoral vs internal jugular insertion: short‐term catheterization
Catheter‐related infectious complication ‐ Subgroup Analysis for the effect of BMI on catheter colonization ‐ Highest BMI tercile (>28.4) · critically ill patients who were expected to require support with renal replacement therapy
Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane
RR 1.69 [1.08, 2.65]1 study · 202 participantsModerate
Femoral vs internal jugular insertion: short‐term catheterization
Catheter‐related thrombotic complications ‐ Symptomatic deep venous thrombosis · critically ill patients who were expected to require support with renal replacement therapy
Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane
RR 0.99 [0.14, 6.98]1 study · 736 participantsModerate
Femoral vs internal jugular insertion: short‐term catheterization
Catheter‐related thrombotic complications ‐ Catheter related thrombosis · critically ill patients who were expected to require support with renal replacement therapy
Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane
RR 0.46 [0.21, 1.01]1 study · 151 participantsModerate
Femoral vs internal jugular insertion: short‐term catheterization
Immediate mechanical complications ‐ Total mechanical complications · critically ill patients who were expected to require support with renal replacement therapy
Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane
RR 0.51 [0.29, 0.88]1 study · 736 participantsModerate
Femoral vs internal jugular insertion: short‐term catheterization
Immediate mechanical complications ‐ Major mechanical complications · critically ill patients who were expected to require support with renal replacement therapy
Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane
RR 0.33 [0.03, 3.16]1 study · 736 participantsModerate
Internal jugular vs subclavian insertion: long‐term catheterization
Catheter‐related infectious complications ‐ Port‐related bacteraemia and/or pocket infections · cancer patients
Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane
RR 0.35 [0.04, 3.32]1 study · 240 participantsModerate
Internal jugular vs subclavian insertion: long‐term catheterization
Catheter‐related thrombotic complications · cancer patients
Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane
RR 1.97 [0.87, 4.48]1 study · 240 participantsModerate
Internal jugular vs subclavian insertion: long‐term catheterization
Immediate mechanical complications ‐ Total mechanical complications · cancer patients
Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane
RR 1 [0.21, 4.84]2 studies · 468 participantsLow
Internal jugular vs subclavian insertion: long‐term catheterization
Immediate mechanical complications ‐ Major mechanical complications · cancer patients
Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane
RR 0.33 [0.01, 8.09]2 studies · 468 participantsLow